Featured Post
Press Release:
Concert Genetics Presents Real-World Data on Utilization of NGS-Based Diagnostic Tests in NCCN 2020 Abstract

NASHVILLE, Tenn. (April 1, 2020) – Concert Genetics, a technology company dedicated to advancing precision medicine, today announced the publication of real-world data on utilization and coding variability in medical claims for Next-Generation Sequencing (NGS)-based diagnostic tests. The study was done in collaboration with Merck, known as MSD outside the United States and Canada, and […]


Wed. April 1, 2020
Read Post